Disease/Infection News

RSS

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 21st European Congress of Clinical Microbiology and Infectious Diseases conference in Milan, Italy highlighting additional analyses of the Phase 3 data of DIFICID for the treatment of Clostridium difficile infection.

11 May 2011

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Sosei Group Corporation, the biopharmaceutical company, today announces that Sosei Co., Ltd., its wholly owned Japanese subsidiary, acquired development and commercialization rights to Loramyc (miconazole Lauriad) in Japan from BioAlliance Pharma.

11 May 2011

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Belgian physicians report they have cured a young patient with extensively drug-resistant tuberculosis (XDR-TB) using a novel two-drug combination developed by researchers at Albert Einstein College of Medicine of Yeshiva University. The report, published in the Pediatric Infectious Disease Journal, marks the first known clinical use of this treatment for XDR-TB, the most deadly form of the disease.

11 May 2011

Patients with pneumonia more likely to die if they have Vitamin D deficiency

A new study published in the journal Respirology reveals that adult patients admitted to the hospital with pneumonia are more likely to die if they have Vitamin D deficiency.

11 May 2011

3M introduces Clean-Trace Hygiene Management System for healthcare facilities

As part of its effort to offer a wide range of environmental hygiene solutions for healthcare facilities, 3M Infection Prevention today announced its 3M™ Clean-Trace™ Hygiene Management System. This solution is designed to help hospitals assess the cleanliness of a surface and validate the efficacy of cleaning protocols and worker performance in less than one minute

11 May 2011

FDA clears Meridian's new C. difficile immunoassay

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new Clostridium difficile immunoassay named Premier C. difficile GDH.

11 May 2011

MIGMH awarded $2.1 million grant for STD/HIV regional educational center

The Mississippi Institute of Geographic and Minority Health (MIGMH) at the University of Mississippi Medical Center (UMMC) has been awarded a three-year, $2.1 million grant to operate a regional educational center for the Centers for Disease Control and Prevention (CDC) to teach interventions that prevent the spread of sexually transmitted diseases and HIV.

10 May 2011

Dalbavancin surveillance antibiotic results for Gram-positive pathogens presented at ECCMID meeting

Durata Therapeutics today announced surveillance data demonstrating potency of the Company's lead antibiotic product, dalbavancin, a long-acting, intravenous lipoglycopeptide, against a broad spectrum of gram-positive bacteria prevalent in recent years.

10 May 2011

HIV drugs can be used to target malaria and other parasitic diseases

Drugs used to treat HIV may form templates for lifesaving drugs targeted at malaria and other parasitic diseases, according to a new study from Cardiff University.

10 May 2011

First study to look at birth-cohort screening outcomes for hepatitis C virus

New research indicates that screening people born between 1946 and 1970 for hepatitis C virus instead of current risk-based screening practices is cost effective and could lead to 106,000 fewer cases of advanced liver disease and 59,000 fewer HCV-related deaths. An estimated 1.6 million U.S. residents ages 40 to 64 are infected with HCV but do not know it.

10 May 2011

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

The Laboratory Department for Probiotics Research at the Juntendo University Graduate School of Medicine studied supplementation of probiotic fermented milk containing Lactobacillus casei strain Shirota in elderly individuals living at a nursing home and confirmed reduced fever associated with acute norovirus gastroenteritis.

10 May 2011

Merck launches 'Hope Against Hepatitis C' education program

Merck, known as MSD outside the United States and Canada, today announced the launch of Hope Against Hepatitis C, a company initiative to increase awareness, prevention and diagnosis of hepatitis C virus infection.

10 May 2011

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results of several studies designed to support the continued advancement of its lead antibiotic, TP-434, a potent new broad-spectrum intravenous antibiotic with oral stepdown potential effective against difficult-to-treat and multidrug-resistant pathogens.

10 May 2011

More than half of all adolescents accept free rapid HIV test after risk assessment survey

Although the Centers for Disease Control and Prevention recommends routine HIV testing for everyone between the ages of 13-64 as part of their regular medical care, testing rates remain low among adolescents.

10 May 2011

Pheromone-based traps for monitoring and catching bed bugs

In the worldwide race to develop a solution, SpringStar Inc, a Seattle-area biotech company, is releasing two new advanced pheromone-based traps for monitoring and catching bed bugs.

10 May 2011

Pfizer presents SA3Ag staphylococcal vaccine Phase 1 trial data at ECCMID/ICC

Inhibitex, Inc., announced today that Pfizer Inc. presented safety and immunogenicity data from a Phase 1 double-blind randomized placebo controlled study in 408 healthy volunteers of a novel three antigen Staphylococcus aureus investigational vaccine at the 21st European Congress of Clinical Microbiology and Infectious Diseases and 27th International Congress of Chemotherapy in Milan, Italy.

10 May 2011

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

For infants and young children with urinary tract infection seen in the ER, a simple ultrasound examination may avoid the need for more complex x-ray tests, reports a study in the May issue of The Pediatric Infectious Disease Journal.

10 May 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Aethlon Medical, Inc. announces that it has submitted a request to the U.S. Food and Drug Administration for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier in the United States.

10 May 2011

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

"Cracking the Safe: Advances in HIV/AIDS Prevention and Treatment" is a one-day symposium at the New York Academy of Sciences examining issues facing researchers working towards the development of an HIV/AIDS vaccine, including updates on current challenges and solutions.

10 May 2011

U.S. boosts Cote d'Ivoire commitment; polio vaccine campaign delayed in country's southern region

The U.S. has pledged an additional $8.5 million to relief efforts in Cote d'Ivoire after post-election violence led to hundreds of thousands of internally displaced people and refugees, Devex reports.

10 May 2011

Disease/Infection News

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Patients with pneumonia more likely to die if they have Vitamin D deficiency

3M introduces Clean-Trace Hygiene Management System for healthcare facilities

FDA clears Meridian's new C. difficile immunoassay

MIGMH awarded $2.1 million grant for STD/HIV regional educational center

Dalbavancin surveillance antibiotic results for Gram-positive pathogens presented at ECCMID meeting

HIV drugs can be used to target malaria and other parasitic diseases

First study to look at birth-cohort screening outcomes for hepatitis C virus

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

Merck launches 'Hope Against Hepatitis C' education program

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

More than half of all adolescents accept free rapid HIV test after risk assessment survey

Pheromone-based traps for monitoring and catching bed bugs

Pfizer presents SA3Ag staphylococcal vaccine Phase 1 trial data at ECCMID/ICC

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

U.S. boosts Cote d'Ivoire commitment; polio vaccine campaign delayed in country's southern region

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News